(Q38933327)

7 September 2017

Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins (English)

1 reference

7 September 2017

1 reference

10

Robin J Shattock

1 reference

7 September 2017

Yalan Liu

1

1 reference

7 September 2017

Sukun Luo

2

1 reference

7 September 2017

Siyi He

3

1 reference

7 September 2017

Mudan Zhang

4

1 reference

7 September 2017

Ping Wang

5

1 reference

7 September 2017

Chang Li

6

1 reference

7 September 2017

Wenjie Huang

7

1 reference

7 September 2017

Bodan Hu

8

1 reference

7 September 2017

George E Griffin

9

1 reference

7 September 2017

Qinxue Hu

11

1 reference

7 September 2017

language of work or name

English

0 references

publication date

27 November 2014

1 reference

7 September 2017

1 reference

7 September 2017

475

1 reference

7 September 2017

96-109

1 reference

Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Quantitative membrane proteomics reveals new cellular targets of viral immune modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

HIV entry and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Different responses of two highly permissive cell lines upon HCV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

The role of Nef in the replication cycle of the human and simian immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

The great escape: viral strategies to counter BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

The formation of microscopic plaques by herpes simplex virus in HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

The tegument protein UL94 of human cytomegalovirus as a binding partner for tegument protein pp28 identified by intracellular imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

BST2/tetherin inhibits dengue virus release from human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Tetherin inhibits HIV-1 release by directly tethering virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Inhibition of Lassa and Marburg virus production by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

A novel gene of HIV-1, vpu, and its 16-kilodalton product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Mechanism of HIV-1 virion entrapment by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

BST2/Tetherin enhances entry of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2014.11.005

1 reference

7 September 2017

1 reference